Hyperinflammatory response in COVID-19: a systematic review

Silva, Marcos Jessé Abrahão; Ribeiro, Layana Rufino; Gouveia, Maria Isabel Montoril; Marcelino, Beatriz dos Reis; Santos, Carolynne Silva dos; Lima, Karla Valéria Batista; Lima, Luana Nepomuceno Gondim Costa.
SILVA, Marcos Jessé Abrahão et al. Hyperinflammatory response in COVID-19: a systematic review. Viruses, v. 15, n. 2, p. 1-38, 2023. DOI: https://doi.org/10.3390/v15020553. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962879/pdf/viruses-15-00553.pdf / SILVA, Marcos Jessé Abrahão et al. Hyperinflammatory response in COVID-19: a systematic review. Viruses, v. 15, n. 2, p. 1-38, 2023. DOI: https://doi.org/10.3390/v15020553. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962879/pdf/viruses-15-00553.pdf
Artigo em Inglês | Instituto Evandro Chagas (DSpace) | ID: ied-6730

Documentos relacionados

  1. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
  2. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
  3. Innate Immunity as an Executor of the Programmed Death of Individual Organisms for the Benefit of the Entire Population.
  4. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
  5. An overview of proteomic methods for the study of 'cytokine storms'.
  6. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
  7. Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19.
  8. SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions.
  9. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
  10. C-reactive protein as an effector molecule in Covid-19 pathogenesis.